Allurion Technologies, Inc. was incorporated under the laws of the State of Delaware on January 25, 2023. The company is committed to ending obesity by creating a best-in-class weight loss platform to treat the estimated 2 billion overweight people worldwide. The company's platform, Allurion Program, utilizes the world's first and only swallowable, programless intragastric weight loss balloon and offers the opportunity to use AI-powered remote patient monitoring tools, proprietary behavior modification programs, secure messaging and video telemedicine, all provided by the company.
